These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12412350)

  • 1. [Legofer--a new approach in the treatment of iron deficiency. Pharmacological and biopharmacological characteristics of legofer (ferric protein succinylate)].
    Akush Ginekol (Sofiia); 2002; 41 Suppl 1():21-3. PubMed ID: 12412350
    [No Abstract]   [Full Text] [Related]  

  • 2. [Iron protein-succinylate in the treatment of adult iron-deficiency anemia].
    Pujol Farriols R; Anglada Oriol M; Formiga Pérez F; Fernández-Sabe N; Mitjavila Vileró F; Vidaller Palacín A
    An Med Interna; 2002 Dec; 19(12):651-2. PubMed ID: 12593038
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative study of tolerability and efficacy of iron protein succinylate versus iron hydroxide polymaltose complex in the treatment of iron deficiency in children.
    Haliotis FA; Papanastasiou DA
    Int J Clin Pharmacol Ther; 1998 Jun; 36(6):320-5. PubMed ID: 9660039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of oral iron protein succinylate: a systematic review of three decades of research.
    Martínez Francés A; Leal Martínez-Bujanda J
    Curr Med Res Opin; 2020 Apr; 36(4):613-623. PubMed ID: 31944128
    [No Abstract]   [Full Text] [Related]  

  • 5. [The efficacy and tolerability of ferroproteinsuccinylate in iron deficiency].
    Scremin S; Caprioglio L
    Boll Chim Farm; 1988 Mar; 127(3):44S-49S. PubMed ID: 3240355
    [No Abstract]   [Full Text] [Related]  

  • 6. [The activity and tolerability of ferroproteinsuccinylate in the treatment of iron deficiency in surgery].
    Ambrosini A
    Boll Chim Farm; 1988 Mar; 127(3):40S-43S. PubMed ID: 3071379
    [No Abstract]   [Full Text] [Related]  

  • 7. Meta-analysis of efficacy and tolerability data on iron proteinsuccinylate in patients with iron deficiency anemia of different severity.
    Köpcke W; Sauerland MC
    Arzneimittelforschung; 1995 Nov; 45(11):1211-6. PubMed ID: 8929242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron protein succynilate in the treatment of iron deficiency: potential interaction with H2-receptor antagonists.
    Bianchi FM; Cavassini GB; Leo P
    Int J Clin Pharmacol Ther Toxicol; 1993 May; 31(5):209-17. PubMed ID: 8100220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron protein succinylate: preclinical safety assessment.
    Forster R
    Int J Clin Pharmacol Ther Toxicol; 1993 Feb; 31(2):53-60. PubMed ID: 8458676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and tolerability of iron protein succinylate in the treatment of iron-deficiency anemia in pregnancy.
    Sifakis S; Angelakis E; Papadopoulou E; Stratoudakis G; Fragouli Y; Koumantakis E
    Clin Exp Obstet Gynecol; 2005; 32(2):117-22. PubMed ID: 16108396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of anti-anaemic effects of iron protein succinylate (ITF 282) and ferrous sulfate in the rat.
    Caramazza I; Andriuoli G; Scagnol I; Del Soldato P
    Drugs Exp Clin Res; 1990; 16(7):333-42. PubMed ID: 2092959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ferroproteinsuccinylate in iron deficiency in obstetric and gynecology].
    Bracchitta R; Santoni G
    Boll Chim Farm; 1988 Mar; 127(3):35S-39S. PubMed ID: 3240354
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of iron deficiency anaemia in pregnant, puerperal and gynaecological patients--different drugs, different approaches].
    Bozhinova S
    Akush Ginekol (Sofiia); 2005; 44(4):46-50. PubMed ID: 16028380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron complex, dabigatran and toxic epidermal necrolysis syndrome: a case-report.
    Tsoumpris A; Tzimas T; Gkabrelas K; Akritidis N
    J Clin Pharm Ther; 2013 Apr; 38(2):177-8. PubMed ID: 23240787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ferroprotein succinylate: treatment of iron deficiency in obstetrics and gynecology].
    Sallusto A; Eandi M; De Bartolo G; Curiale C; Massobrio M
    Minerva Ginecol; 1990 May; 42(5):191-5. PubMed ID: 2374653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron Protein Succinylate in the Management of Iron Deficiency Anemia: A Comparative Study with Ferrous Sulphate at Low and High Therapeutic Doses.
    Urso K; Leal Martínez-Bujanda J; Del Prado JM
    Nutrients; 2021 Mar; 13(3):. PubMed ID: 33802720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of iron deficiency conditions in blood donors: controlled study of iron sulphate versus iron protein succinylate.
    Landucci G; Frontespezi S
    J Int Med Res; 1987; 15(6):379-82. PubMed ID: 3325320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tot'hema--alternative in the treatment of iron deficiency and iron deficiency anemia].
    Sigridov I; Ivanov S
    Akush Ginekol (Sofiia); 2004; 43 Suppl 2():28-9. PubMed ID: 15518272
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparative study on the gastroduodenal tolerance of different antianaemic preparations.
    Idoate Gastearena MA; Gil AG; Azqueta A; Coronel MP; Gimeno M
    Hum Exp Toxicol; 2003 Mar; 22(3):137-41. PubMed ID: 12723894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study of iron protein succinylate oral solution for preventing and treating anemia of prematurity].
    Xing Y; Tong XM
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Dec; 15(12):1059-63. PubMed ID: 24342196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.